Industry News

Arbutus Biopharma Corporation, an industry-leading hepatitis B virus therapeutic solutions company, today announced presentation of data at the 2016 American Association for the Study of Liver Diseases Liver Meeting being held on November 11– 15, 2016, at the John B. Hynes Veterans Memorial Convention Center, Boston.. “We are continuously generating preclinical combination data to inform our clinical development..."/>
Arbutus to Present HBV Data at the 2016 AASLD Liver Meeting
MorphoSys AG announced today that its licensee Janssen Research& Development, LLC has reported positive results from a clinical phase 3 study examining guselkumab, a fully human antibody intended to target IL-23 identified from MorphoSys's HuCAL antibody library, in 837 patients with moderate to severe plaque psoriasis. Janssen stated in a press release issued today that "new phase 3 data show significant efficacy versus placebo and..."/>
Ad hoc: MorphoSys Announces That Its Licensee Janssen Reports Positive Results From A Phase 3 Study of Guselkumab in Plaque Psoriasis
AstraZeneca Pharma India sent a letter to around 50 employees, inviting them to Bangalore to participate in a discussion regarding restructuring of the firm's business. The letter said the UK-headquarter pharma major has globally launched the "Focus to Win" initiative to align its resources with strategic objectives. The mail had attached flight tickets, airport pickup-and-drop details, hotel booking..."/>
Astra Zeneca gives pink slips to execs, to reduce headcount by one-fourth [Hindustan Times, New Delhi]
Dermira, Inc., a biopharmaceutical company dedicated to identifying, developing and commercializing innovative, differentiated therapies to improve the lives of patients with dermatologic diseases, today presented data, including new disease-related quality of life data, from its DRM04 Phase 3 clinical program in patients with primary axillary hyperhidrosis in a late-breaking news session at the 25 th European Academy of Dermatology and..."/>
Dermira Presents Data from DRM04 Phase 3 Clinical Program in Late-Breaking News Session at European Academy of Dermatology and Venereology Congress
Seres Therapeutics. Investors who purchased or otherwise acquired shares between June 25, 2015 and July 29, 2016 inclusive, are encouraged to contact the Firm prior to the November 28, 2016 lead plaintiff motion deadline.. If you purchased shares of Seres during the Class Period, please contact Joon M. Khang, Esquire, of Khang& Khang LLP, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by..."/>
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Seres Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
Regeneron Pharmaceuticals, Inc. and Sanofi today announce that detailed results from LIBERTY AD SOLO 1 and SOLO 2, two placebo-controlled Phase 3 studies evaluating investigational Dupixent ® in adult patients with inadequately controlled moderate-to-severe atopic dermatitis, were published in the New England Journal of Medicine. The studies met their primary endpoints evaluating the extent and severity of the disease."/>
Regeneron and Sanofi Announce Positive Dupixent® (dupilumab) Phase 3 Atopic Dermatitis Data Published in the New England Journal of Medicine
Veracyte, Inc., a genomic diagnostics company focused on reducing diagnostic uncertainty, today issued the statement below on the Centers for Medicare and Medicaid Services' final 2017 "gapfill" Medicare reimbursement rate for the Afirma Gene Expression Classifier, which the agency released this afternoon. The rate is intended to be in effect for one year before new Medicare rates based on private-payer reimbursement..."/>
Veracyte Releases Statement on CMS's Final 2017 Gapfill Rate for the Afirma® Gene Expression Classifier
Rennova Health, a medical testing firm headquartered in West Palm Beach, remains the worst performer among local stocks. Shares have plunged 86 percent in the first nine months of the year."/>
3 THINGS TO KNOW: Local Company StocksWho's up, down through Q3 [The Palm Beach Post, Fla.]
OncBioMune Pharmaceuticals Inc., a Baton Rouge firm that has developed a vaccine for prostate cancer, is in talks to acquire Vitel Laboratorios S.A., a Mexico City firm that licenses and distributes over-the-counter drugs. The companies have been talking since January, when OncBioMune's chief executive officer, Jonathan Head, sat next to Vitel CEO Manuel Cosme Odabachian on a flight following JPMorgan Chase's annual health care conference, said OncBioMune President..."/>
Baton Rouge biopharma firm in talks to acquire Mexican firm [The Advocate, Baton Rouge, La.]
National HealthCare Corporation, the nation's oldest publicly traded senior health care company, today announced that both Donald K. Daniel and Charlotte A. Swafford have informed the Board of Directors that they plan to retire from their positions within the company effective December 31, 2016. Swafford will be leaving her position as Senior Vice President and Treasurer, a position that she has held since 1985."/>
Donald Daniel and Charlotte Swafford Announce Retirement
Teleflex Incorporated, a leading global provider of medical devices for critical care, urology and surgery, is committed to connecting clinicians with technology in a way that improves clinical practice and advances patient outcomes. Teleflex will present its innovative intraosseous vascular access system and products for rescue airway, atomization and intubation needs at the European Society for Emergency Medicine in Vienna, Austria on October 2-5, 2016.."/>
Teleflex to Present at European Society for Emergency Medicine (EuSEM), in Vienna, Austria
Invacare Corporation. ProBasics, a line of durable medical equipment, has long been Invacare’ s value brand for home medical equipment providers that are seeking quality DME products at a price that supports today’ s reimbursement..."/>
Compass Health Brands Acquires the ProBasics Brand from Invacare
Retrophin, Inc. today announced that its Board of Directors has granted an inducement award pursuant to Rule 5635 (c) of the NASDAQ Listing Rules to Julio Gagne in connection with his employment as vice president, Program Management.. Gagne’ s employment with Retrophin began today, September 30, 2016. Gagne’ s inducement award consists of a stock option to purchase 60,000 shares of Retrophin common stock."/>
Retrophin Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
Surgery Partners, Inc., today announced the appointment of Teresa DeLuca, M.D. to its Board of Directors effective September 30, 2016. In addition to serving on the Board of Directors, Dr. DeLuca will serve on the Company’ s Audit Committee.."/>
Surgery Partners, Inc. Appoints Teresa DeLuca, M.D. to the Board of Directors
Chiasma, Inc., a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today announced that Mark J. Fitzpatrick has been appointed President and Chief Executive Officer and a member of the company’ s Board of Directors, effective October 1, 2016. Fitzpatrick currently serves as Chiasma’ s Chief Financial Officer. He succeeds Mark Leuchtenberger, who has stepped down as Chief Executive Officer to..."/>
Chiasma Names Mark J. Fitzpatrick Chief Executive Officer
Masimo announced today that it is partnering with Smile Train to help ensure the safety of patients undergoing cleft lip and/or palate surgery in low-resource settings around the world. Patient monitoring, including the use of pulse oximetry, is a key part of ensuring safe surgical care; however, in lower-resource settings essential monitoring equipment is often unavailable, particularly in the post-operative period. 1 Working together, Smile Train and..."/>
Masimo Partners with Smile Train to Advance Safe Surgery
AVEO Pharmaceuticals, Inc., et al., Civil Action No. 1:14- cv-11672-DJC."/>
AVEO Oncology Announces Proposed Settlement and Settlement Hearing in 2014 Stockholder Litigation
Five Star Quality Care, Inc., one of the nation’ s leading senior living and healthcare services providers which does business under the name“ Five Star Senior Living”, today announced that seven communities participated at“ A Taste of Senior Living” in Clarksville, Maryland. The Lifespan Network invited Senior Living communities to feature dishes served to residents and a panel of judges critiqued the entrants based upon taste, texture and appearance."/>
Five Star Senior Living Has Seven Communities Compete in “A Taste of Senior Living” in Clarksville, Maryland
Invacare Corporation announced today that it has completed the sale of its subsidiary, Garden City Medical, Inc., dba PMI and Pinnacle Medsource, which sources and distributes primarily single-use products under the brand ProBasics ® by PMI, to Compass Health Brands for approximately $13.8 million in cash, subject to certain post-closing adjustments. As part of the transition, Invacare will cease selling the ProBasics products after a 15- day transition period."/>
Invacare Corporation Announces Sale of ProBasics Brand in Line with Transformation Strategy
Constellation Healthcare Technologies, Inc said. On 23 September, Constellation Healthcare Technologies agreed to..."/>
Constellation Healthcare Holds Earnout Shares in Escrow in Vega Medical Professionals Deal
Depomed, Inc. today announced that Judge Claire C. Cecchi of the United States District Court for the District of New Jersey has ruled in favor of Depomed in the company's patent litigation against all three filers of Abbreviated New Drug Applications for Depomed's NUCYNTA franchise. With the court’ s ruling, Depomed expects market exclusivity until December 2025 for NUCYNTA ® ER, NUCYNTA ® and NUCYNTA ® oral solution. 1. “We are pleased with the Court’ s..."/>
Depomed Prevails in NUCYNTA Franchise ANDA Litigation Providing Market Exclusivity Until December 2025
Prothena Corporation plc, announced today that its Co-founder, President and Chief Executive Officer, Dr. Dale B. Schenk, passed away this morning, after confronting his pancreatic cancer with the same courage, determination and humor that pervaded all areas of his life.. “Dale was a dear friend and colleague, and the broader scientific community has lost an incredibly innovative and creative leader,” stated Lars G. Ekman, MD, PhD, Chairman of the Prothena..."/>
In Memoriam – Friend, Scientific Innovator and Leader Dr. Dale B. Schenk has Passed Away

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Information Technology770 Articles
Consumer Discretionary692 Articles
Financials539 Articles
Health Care440 Articles
Industrials435 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.